CLOs on the Move

STS Life Sciences Division, Ethox International

www.stsduotek.com

 
STS Life Sciences Division, Ethox International is a Rush, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Surgimedics

Surgimedics is a Lake City, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioVentrix

BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA.

Ottobock North America

Ottobock was founded in Germany in 1919 by Otto Bock, a prosthetist. His vision of restoring mobility lives on today, growing to serve the world with more than 46 locations reaching more than 100 countries. The company is headquartered in Duderstadt, Germany, and has more than 5,000 employees.   In the early 20th century, Otto Bock transformed the way prosthetic limbs were made. Instead of carving wood to fit a patient, he applied manufacturing techniques and created separate components (like knees and feet) that could be combined, altered or customized to create a limb that was still unique to each patient – but wasn’t built from scratch.   Because of his pioneering work, Prosthetists were able to meet the demand generated by World War I and help veterans stay as active as possible.   In 1958, our North American headquarters were established in Minneapolis, Minnesota. Our Canadian branch was founded in 1978 and is currently located in Toronto, Ontario. As the first branch, North America has led the way in advocating for and supporting local needs while still tapping into a global network of research and development, manufacturing, and clinical expertise. The people who use our products benefit from the synergy of a worldwide organization complemented by a local connection.   Finally, Ottobock continues to give back to the community, supporting various charities and projects that are consistent with our mission of restoring independence.

AtriCure

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 100,000 implanted to date.

Minnetronix

Minnetronix, Inc. is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.